...
首页> 外文期刊>BMC Health Services Research >A cross-sectional study: medication safety among cancer in-patients in tertiary care hospitals in KPK, Pakistan
【24h】

A cross-sectional study: medication safety among cancer in-patients in tertiary care hospitals in KPK, Pakistan

机译:一项横断面研究:巴基斯坦KPK三级医院的癌症住院患者的用药安全性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Medication safety in cancer patients receiving complex medication regimens is an important problem in various settings. Medication related events, interceptions and interventions are not well described in this area. We intended to study incidence, types, settings and stages involved, root cause analysis, medication classes involved and the level of harm cause by medication errors in two hospitals providing oncology services comparatively. The severity of incidents and interventions are studied. It was a prospective cross sectional study among cancer in-patients of two tertiary care hospitals of KPK. Scale by NCC-MERP was used for evaluation of all medication related incidents. The data obtained was analyzed by IBM SPSS statistics 22 with 95% confidence interval and used the same for other descriptive statistics. All medication orders were reviewed at both sites (Computerized Prescription Order Entry and HWP systems). Potential ADEs incidence was found high at site 2 (97.5%) while medication errors without harm was high at site 1 (97.5%). Most events occur at prescribing level 87.6 and 81.7% at both sites 1 and 2. Types highly reported involved improper dose 31.4 and 15.5%, monitoring error 14.6 and 15.2% at site 1 and 2. Medications involved in these incidents were antibiotics 44 and 12.7%, antiemetic 7.5 and 15.8% and antineoplastic 2.9 and 9.4% at site 1 and 2. Severity of 3.6 and 36.5% incidents had potential to cause harm at site 1 and 2. Root causes were human factors 62.6 and 72.3%, drug selection 33.6 and 38.8%, and dose selection 39.6 and 15.3% at sites 1 and 2. Contributing factors including staff training 33.6 and 24.3%, system for covering patient care 14.9 and 36.6%, communication system 2.4 and 20.3%, interruptions 9.7 and 7.3% and others 78.8 and 68.6% were highly reported. Preventability of medication errors was 99% at both sites. Intervention was taken in 90.5% events at site 1 (CPOE system) while the incidence lowest at site 2 (HWP system). Medication related events are high among cancer in-patients at the site lacking updated electronic system for medication prescribing. Proper training about medication safety, reporting and interventions are required.
机译:在各种情况下,接受复杂药物治疗方案的癌症患者的药物治疗安全性是一个重要问题。与药物相关的事件,拦截和干预措施在该领域没有得到很好的描述。我们打算在提供肿瘤学服务的两家医院中比较研究发生率,类型,设置和阶段,根本原因分析,涉及的用药类别以及用药错误造成的伤害程度。研究了事件和干预的严重性。这项前瞻性横断面研究在KPK的两家三级医院的癌症住院患者中进行。 NCC-MERP的量表用于评估所有与药物相关的事件。通过IBM SPSS统计22以95%的置信区间对获得的数据进行了分析,并将其用于其他描述性统计。在两个站点(计算机处方订单输入和HWP系统)均审核了所有药物订单。发现潜在的ADEs发生率在部位2较高(97.5%),而没有伤害的用药错误在部位1较高(97.5%)。大多数事件都发生在处方1和2的87.6和81.7%的处方水平上。高度报告的类型涉及剂量不正确的31.4和15.5%,在部位1和2的监测错误为14.6和15.2%。涉及这些事件的药物是抗生素44和12.7。 %,止吐药7.5和15.8%,以及在第1和2位的抗肿瘤药2.9和9.4%。严重程度为3.6和36.5%的事故可能在第1和2位造成伤害。根本原因是人为因素,分别为62.6和72.3%,药物选择33.6和38.8%,以及站点1和2的剂量选择39.6和15.3%。影响因素包括员工培训33.6和24.3%,覆盖患者护理系统14.9和36.6%,通信系统2.4和20.3%,中断9.7和7.3%和其他的78.8和68.6%被高度报道。在两个地点的用药错误可预防性均为99%。干预发生在站点1(CPOE系统)的90.5%事件中,而在站点2(HWP系统)的发生率最低。在缺乏更新的电子处方系统的现场,癌症患者中与药物相关的事件很高。需要对药物安全性,报告和干预措施进行适当的培训。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号